LDHA and chronic myelogenous leukemia, BCR-ABL1 positive: Deletion of PKM2 or LDHA manifested by delay in the initiation of leukemogenesis in both BCR-ABL-transformed stem cells (CML) and MLL-AF9-transformed progenitor cells (AML) [6].